Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells

Colorectal cancer (CRC) is one of the most frequently diagnosed malignancies. The generation of conventional treatments has improved, but approximately 50 % of patients with CRC who undergo potentially curative surgery ultimately relapse and die, usually as a consequence of metastatic disease. Our p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical & experimental metastasis 2016-06, Vol.33 (5), p.441-451
Hauptverfasser: de Lacerda, Tonielli Cristina Sousa, Costa-Silva, Bruno, Giudice, Fernanda Salgueiredo, Dias, Marcos Vinicios Salles, de Oliveira, Gabriela Pintar, Teixeira, Bianca Luise, dos Santos, Tiago Goss, Martins, Vilma Regina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Colorectal cancer (CRC) is one of the most frequently diagnosed malignancies. The generation of conventional treatments has improved, but approximately 50 % of patients with CRC who undergo potentially curative surgery ultimately relapse and die, usually as a consequence of metastatic disease. Our previous findings showed that engagement of the cellular prion protein (PrP C ) to its ligand HSP70/90 heat shock organizing protein (HOP) induces proliferation of glioblastomas. In addition, PrP C has been described as an important modulator of colorectal tumor growth. Here, we investigated the biological relevance of the PrP C -HOP interaction in CRC cells. We demonstrate that HOP induced the migration and invasion of CRC cell lines in a PrP C -dependent manner and that phosphorylation of the ERK1/2 pathway is a downstream mediator of these effects. Additionally, we show that a HOP peptide with the ability to bind PrP C and abolish the PrP C -HOP interaction inhibited the migration and invasion of CRC cells. Together, these data indicate that the disruption of the PrP C -HOP complex could be a potential therapeutic target for modulating the migratory and invasive cellular properties that lead to metastatic CRC.
ISSN:0262-0898
1573-7276
DOI:10.1007/s10585-016-9788-8